Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
1 raison identifiée
Délais de RDV courts dans la région
153.9 rhumatos / 100 000 hab. — département bien doté
4 publications sur 5 ans
✨ Génération du profil synthétique IA en cours…
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Influence scientifique
11
11 articles ont été cités au moins 11fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
h-index
Total citations reçues
247
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
25
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
12
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Affiliations FR : Sorbonne Université · Centre Hospitalier Universitaire de Tours · Assistance Publique – Hôpitaux de Paris
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Cerebral Amyloid Angiopathy-Related Inflammation and Biopsy-Positive Primary Angiitis of the CNS: A Comparative Study.
2024ArticleNeurology
Different Clinical Outcomes between Cerebral Amyloid Angiopathy-Related Inflammation and Non-Inflammatory Form.
2022ArticleJournal of Neurology
Long-Term Effectiveness, Safety and Tolerability of Fingolimod in Patients with Multiple Sclerosis in Real-World Treatment Settings in France: The VIRGILE Study
2022ArticleNeurology and Therapy
DWI cerebellar infarct volume as predictor of outcomes after endovascular treatment of acute basilar artery occlusion
2020ArticleJournal of Neurointerventional Surgery
A Clinico-Radiological Study of Cerebral Amyloid Angiopathy-Related Inflammation
2019ArticleCerebrovascular Diseases
A Regional Network Organization for Thrombectomy for Acute Ischemic Stroke in the Anterior Circulation; Timing, Safety, and Effectiveness
2019ArticleJournal of Stroke and Cerebrovascular Diseases
Cerebral Amyloid Angiopathy and Cerebral Amyloid Angiopathy-Related Inflammation: Comparison of Hemorrhagic and DWI MRI Features
2018ArticleJournal of Alzheimer's Disease
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
CH BEZIERS
ZAC DE MONTMIRAN 2 R VALENTIN HAUY BP 740, 34525 BEZIERS CEDEX
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Journal of Alzheimer's disease : JAD · 2018
Background: Cerebral amyloid angiopathy (CAA) can be associated with primary vasculitis of small/medium-sized leptomeningeal and cortical arteries, called CAA-related inflammation (CAA-ri). Objective: To compare hemorrhagic and diffusion-weighted imaging (DWI) MRI features in CAA and CAA-ri. Methods: We prospectively scored in a consecutive CAA and CAA-ri cohort: presence/number of chronic intracerebral hemorrhage (ICH), cerebral microbleeds (CMB), and cortical superficial siderosis (CSS) on initial T2*-weighted imaging, and DWI lesions on both initial and follow-up imaging. In a subgroup, ApoE, CSF, and 18F-florbetaben-positron emission tomography (FBB-PET) were also analyzed. Results: In CAA-ri, CMB presence was more frequent (100% versus 40%, p < 0.001) and CMB numbers higher (mean 137 versus 8, p < 0.001). No difference was observed for chronic ICH or CSS. DWI lesions were more frequent in acute compared to chronic CAA-ri ( p = 0.025), whereas no such difference was observed between acute and chronic CAA ( p = 0.18). Both ApoE4 (genotyping available in 22 CAA-ri and 48 CAA patients) carriers and homozygosity were more frequent in CAA-ri (48% versus 19% [ p = 0.014] and 32% versus 2% [ p < 0.001] respectively). CSF biomarker analyses (performed in 20 CAA-ri and 45 CAA patients) showed lower A β 42 levels in CAA-ri compared to CAA (median 312 versus 422 pg/mL, p = 0.0032). FBB-PET (performed in 11 CAA-ri and 20 CAA patients) showed higher standardized uptake value ratios in CAA-ri compared with CAA, only significant when the pons was used as reference ( p = 0.037). Conclusion: Compared to CAA, CAA-ri was associated with higher CMB numbers, more frequent ApoE4 carriers and homozygotes, lower CSF A β 42 levels, and more severe amyloid load on FBB-PET.
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association · 2019
Journal of neurointerventional surgery · 2021
BackgroundPreprocedural predictors of outcome in patients with acute basilar artery occlusion (ABAO) who have undergone endovascular treatment (EVT) remain controversial. Our aim was to determine if pre-EVT diffusion-weighted imaging cerebellar infarct volume (CIV) is a predictor of 90-day outcomes.MethodsWe analyzed consecutive MRI-selected endovascularly treated patients with ABAO within the first 24 hours after symptom onset. Successful reperfusion was defined as a modified Thrombolysis in Cerebral Infarction score of 2b–3. Using the initial MRI, baseline CIV was calculated in mL on an apparent diffusion coefficient map reconstruction (Olea Sphere software). CIV was analyzed in univariate and multivariable models as a predictor of 90-day functional independence (modified Rankin Scale (mRS) 0–2) and mortality. According to receiver operating characteristic (ROC) analysis, the optimal cut-off was determined by maximizing the Youden index to evaluate the prognostic value of CIV.ResultsOf the 110 MRI-selected patients with ABAO, 64 (58.18%) had a cerebellar infarct. The median CIV was 9.6 mL (IQR 2.7–31.4). Successful reperfusion was achieved in 81.8% of the cases. At 90 days the proportion of patients with mRS ≤2 was 31.8% and the overall mortality rate was 40.9%. Baseline CIV was significantly associated with 90-day mRS 0–2 (p=0.008) in the univariate analysis and was an independent predictor of 90-day mortality (adjusted OR 1.79, 95% CI 1.25 to 2.54, p=0.001). The ROC analysis showed that a CIV ≥4.7 mL at the initial MRI was the optimal cut-off to discriminate patients with a higher risk of death at 90 days (area under the ROC curve (AUC)=0.74, 95% CI 0.61 to 0.87, sensitivity and specificity of 87.9% and 58.1%, respectively).ConclusionsIn our series of MRI-selected patients with ABAO, pre-EVT CIV was an independent predictor of 90-day mortality. The risk of death was increased for baseline CIV ≥4.7 mL.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Journal of neurointerventional surgery · 2021 · Journal Article
Mourand I, Mahmoudi M, Dargazanli C, Pavillard F, et al.
Journal of Alzheimer's disease : JAD · 2018 · Journal Article
Renard D, Tatu L, Collombier L, Wacongne A, et al.
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association · 2019 · Comparative Study
Mourand I, Malissart P, Dargazanli C, Nogue E, et al.
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association · 2019 · Comparative Study
Mourand I, Malissart P, Dargazanli C, Nogue E, et al.
✨ Profil synthétique
IA · 22/05/2026Le Dr M YASSINE BOUKRICHE est un rhumatologue salarié à Béziers, avec une production scientifique notoire. Ses recherches portent principalement sur des sujets neurologiques, bien que son exercice professionnel soit en rhumatologie. Il compte 25 publications et un h-index de 11 selon OpenAlex.
Expertises présumées
Synthèse automatique à partir des sources publiques (HAL, OpenAlex, theses.fr, ClinicalTrials.gov, FAI²R, ANS). Pas une évaluation clinique. Le médecin peut corriger via son compte.